First Evidence for Disease-Modifying Treatment of SLC20A2-Related Primary Familial Brain Calcification

^*Korrespondierende/r Autor/-in für diese Arbeit

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

@article{f35af4e5385a49d8afa85c0f9f6d4861,

title = "First Evidence for Disease-Modifying Treatment of SLC20A2-Related Primary Familial Brain Calcification",

author = "Alexander Balck and Christine Klein",

year = "2024",

month = dec,

doi = "10.1002/mds.30034",

language = "English",

volume = "39",

pages = "2180",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley \& Sons Inc.",

number = "12",

}

TY - JOUR

T1 - First Evidence for Disease-Modifying Treatment of SLC20A2-Related Primary Familial Brain Calcification

AU - Balck, Alexander

AU - Klein, Christine

PY - 2024/12

Y1 - 2024/12

UR - https://www.scopus.com/pages/publications/85206924037

U2 - 10.1002/mds.30034

DO - 10.1002/mds.30034

M3 - Comments/Debates

C2 - 39428678

AN - SCOPUS:85206924037

SN - 0885-3185

VL - 39

SP - 2180

JO - Movement Disorders

JF - Movement Disorders

IS - 12

ER -